91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Melanoma - Pipeline Review, H2 2020

Melanoma - Pipeline Review, H2 2020

Publication ID: 
GMD1120079
Publication Date: 
November 30, 2020
Pages: 
3809
Publisher: 
Global Markets Direct
Countries: 
Global [1]
USD 2,500.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Drug Pipeline [2]
Pharma & Healthcare [3]
Description: 

Melanoma - Pipeline Review, H2 2020

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Pipeline Review, H2 2020, provides an overview of the Melanoma (Oncology) pipeline landscape.

Melanoma is a tumor that develops as a result of the malignant transformation of melanocytes. These cells are derived from the neural crest. Melanomas usually occur on the skin but can arise in other locations where neural crest cells migrate, such as in the gastrointestinal tract or brain. It is more common in women than in men. In women, the most common site is the legs and melanomas in men are most common on the back. Unusual moles, sores, lumps, blemishes, markings, or changes in the way an area of the skin looks or feels are sign of melanoma. Treatment includes surgery, radiation and proton therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Melanoma - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Melanoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 1, 25, 182, 209, 2, 13, 297, 40 and 4 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 2, 25, 20, 86 and 12 molecules, respectively.

Melanoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct鈥檚 proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Melanoma (Oncology).
- The pipeline guide reviews pipeline therapeutics for Melanoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Melanoma (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Melanoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Melanoma (Oncology)

Reasons to Buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Melanoma (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it鈥檚 most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Melanoma (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table Of Contents: 

Table of Contents
Introduction
Melanoma- Overview
Melanoma- Therapeutics Development
Melanoma- Therapeutics Assessment
Melanoma- Companies Involved in Therapeutics Development
Melanoma- Drug Profiles
Melanoma- Dormant Projects
Melanoma- Discontinued Products
Melanoma- Product Development Milestones
Appendix

List of Tables
List of Tables
Number of Products under Development for Melanoma, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Melanoma - Pipeline by 4D Pharma Plc, H2 2020
Melanoma - Pipeline by 4SC AG, H2 2020
Melanoma - Pipeline by 7 Hills Pharma LLC, H2 2020
Melanoma - Pipeline by AbbVie Inc, H2 2020
Melanoma - Pipeline by Abcuro Inc, H2 2020
Melanoma - Pipeline by Abion Inc, H2 2020
Melanoma - Pipeline by Abivax SA, H2 2020
Melanoma - Pipeline by ABM Therapeutics Inc, H2 2020
Melanoma - Pipeline by AC Bioscience SA, H2 2020
Melanoma - Pipeline by Accendatech Co Ltd, H2 2020
Melanoma - Pipeline by Accuitis Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Acepodia Biotech Inc, H2 2020
Melanoma - Pipeline by ACF Pharmaceuticals LLC, H2 2020
Melanoma - Pipeline by Achilles Therapeutics Ltd, H2 2020
Melanoma - Pipeline by Actym Therapeutics Inc, H2 2020
Melanoma - Pipeline by Adaptimmune Therapeutics Plc, H2 2020
Melanoma - Pipeline by Adare Pharma Solutions, H2 2020
Melanoma - Pipeline by ADC Therapeutics SA, H2 2020
Melanoma - Pipeline by Adicet Bio Inc, H2 2020
Melanoma - Pipeline by Adjuvance Technologies Inc, H2 2020
Melanoma - Pipeline by Adlai Nortye Biopharma Co Ltd, H2 2020
Melanoma - Pipeline by Advanced BioDesign, H2 2020
Melanoma - Pipeline by Advantageous Systems LLC, H2 2020
Melanoma - Pipeline by Advenchen Laboratories LLC, H2 2020
Melanoma - Pipeline by Aeglea BioTherapeutics Inc, H2 2020
Melanoma - Pipeline by Afecta Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Affichem SA, H2 2020
Melanoma - Pipeline by AgenTus Therapeutics Inc, H2 2020
Melanoma - Pipeline by Agenus Inc, H2 2020
Melanoma - Pipeline by AGV Discovery SAS, H2 2020
Melanoma - Pipeline by AIM ImmunoTech Inc, H2 2020
Melanoma - Pipeline by AIMM Therapeutics BV, H2 2020
Melanoma - Pipeline by AiVita Biomedical Inc, H2 2020
Melanoma - Pipeline by Akeso Inc, H2 2020
Melanoma - Pipeline by Alkermes Plc, H2 2020
Melanoma - Pipeline by Allarity Therapeutics A/S, H2 2020
Melanoma - Pipeline by Allergy Therapeutics Plc, H2 2020
Melanoma - Pipeline by Alligator Bioscience AB, H2 2020
Melanoma - Pipeline by AlphaMab Co Ltd, H2 2020
Melanoma - Pipeline by Alphamab Oncology, H2 2020
Melanoma - Pipeline by ALS Biopharma LLC, H2 2020
Melanoma - Pipeline by Altor Bioscience LLC, H2 2020
Melanoma - Pipeline by Amgen Inc, H2 2020
Melanoma - Pipeline by Anaveon AG, H2 2020
Melanoma - Pipeline by Andes Biotechnologies, H2 2020
Melanoma - Pipeline by AnGes Inc, H2 2020
Melanoma - Pipeline by Antengene Corp, H2 2020
Melanoma - Pipeline by AntiCancer Inc, H2 2020
Melanoma - Pipeline by APEIRON Biologics AG, H2 2020
Melanoma - Pipeline by Apexian Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Apexigen Inc, H2 2020
Melanoma - Pipeline by Aphios Corp, H2 2020
Melanoma - Pipeline by APO-T BV, H2 2020
Melanoma - Pipeline by Apogenix AG, H2 2020
Melanoma - Pipeline by Apollomics Inc, H2 2020
Melanoma - Pipeline by Arcus Biosciences Inc, H2 2020
Melanoma - Pipeline by Ardan Pharma, H2 2020
Melanoma - Pipeline by Arisaph Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Asana BioSciences LLC, H2 2020
Melanoma - Pipeline by Ascentage Pharma Group International, H2 2020
Melanoma - Pipeline by Astex Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by AstraZeneca Plc, H2 2020
Melanoma - Pipeline by Athenex Inc, H2 2020
Melanoma - Pipeline by Atreca Inc, H2 2020
Melanoma - Pipeline by aTyr Pharma Inc, H2 2020
Melanoma - Pipeline by Aurigene Discovery Technologies Ltd, H2 2020
Melanoma - Pipeline by Autolus Therapeutics Plc, H2 2020
Melanoma - Pipeline by Avalia Immunotherapies Ltd, H2 2020
Melanoma - Pipeline by AVAX Technologies Inc, H2 2020
Melanoma - Pipeline by Avidin Biotechnology Ltd, H2 2020
Melanoma - Pipeline by Avotres Inc, H2 2020
Melanoma - Pipeline by Bantam Pharmaceutical LLC, H2 2020
Melanoma - Pipeline by Barricade Therapeutics Corp, H2 2020
Melanoma - Pipeline by Batu Biologics Inc, H2 2020
Melanoma - Pipeline by Bayer AG, H2 2020
Melanoma - Pipeline by BeiGene Ltd, H2 2020
Melanoma - Pipeline by Beijing Kawin Technology Share-Holding Co Ltd, H2 2020
Melanoma - Pipeline by Beijing Neoantigen Biotechnology Co Ltd, H2 2020
Melanoma - Pipeline by BerGenBio ASA, H2 2020
Melanoma - Pipeline by Bessor Pharma LLC, H2 2020
Melanoma - Pipeline by Betta Pharmaceuticals Co Ltd, H2 2020
Melanoma - Pipeline by Binjiang Pharma, Inc., H2 2020
Melanoma - Pipeline by Bio-Cancer Treatment International Ltd, H2 2020
Melanoma - Pipeline by Bio-Thera Solutions Ltd, H2 2020
Melanoma - Pipeline by BioAtla LLC, H2 2020
Melanoma - Pipeline by Biocad, H2 2020
Melanoma - Pipeline by Biogazelle NV, H2 2020
Melanoma - Pipeline by Biogen Inc, H2 2020
Melanoma - Pipeline by Biohaven Pharmaceutical Holding Company Ltd, H2 2020
Melanoma - Pipeline by BioInvent International AB, H2 2020
Melanoma - Pipeline by BioLineRx Ltd, H2 2020
Melanoma - Pipeline by BioMed Valley Discoveries Inc, H2 2020
Melanoma - Pipeline by Bionomics Ltd, H2 2020
Melanoma - Pipeline by BioNTech SE, H2 2020
Melanoma - Pipeline by Bioquark Inc, H2 2020
Melanoma - Pipeline by Biosion Inc, H2 2020
Melanoma - Pipeline by BioVaxys Technology Corp, H2 2020
Melanoma - Pipeline by Biovista Inc, H2 2020
Melanoma - Pipeline by BioXcel Therapeutics Inc, H2 2020
Melanoma - Pipeline by BJ Bioscience Inc, H2 2020
Melanoma - Pipeline by Boehringer Ingelheim International GmbH, H2 2020
Melanoma - Pipeline by BriaCell Therapeutics Corp, H2 2020
Melanoma - Pipeline by BridgeBio Pharma Inc, H2 2020
Melanoma - Pipeline by BrightPath Biotherapeutics Co Ltd, H2 2020
Melanoma - Pipeline by Bristol-Myers Squibb Co, H2 2020
Melanoma - Pipeline by Bromodomain Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Byondis BV, H2 2020
Melanoma - Pipeline by Calidi Biotherapeutics Inc, H2 2020
Melanoma - Pipeline by Calithera Biosciences Inc, H2 2020
Melanoma - Pipeline by Can-Fite BioPharma Ltd, H2 2020
Melanoma - Pipeline by Cancure Ltd, H2 2020
Melanoma - Pipeline by Cantargia AB, H2 2020
Melanoma - Pipeline by CDR-Life Inc, H2 2020
Melanoma - Pipeline by Celdara Medical LLC, H2 2020
Melanoma - Pipeline by Celldex Therapeutics Inc, H2 2020
Melanoma - Pipeline by Cellestia Biotech AG, H2 2020
Melanoma - Pipeline by Cellid Co Ltd, H2 2020
Melanoma - Pipeline by Celprogen Inc, H2 2020
Melanoma - Pipeline by Centurion BioPharma Corp, H2 2020
Melanoma - Pipeline by Checkmate Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Checkpoint Therapeutics Inc, H2 2020
Melanoma - Pipeline by Chineo Med Beijing Co Ltd, H2 2020
Melanoma - Pipeline by Chinook Therapeutics Inc, H2 2020
Melanoma - Pipeline by Chugai Pharmaceutical Co Ltd, H2 2020
Melanoma - Pipeline by Cloaked Therapeutics LLC, H2 2020
Melanoma - Pipeline by Codagenix Inc, H2 2020
Melanoma - Pipeline by Codiak BioSciences Inc, H2 2020
Melanoma - Pipeline by CohBar Inc, H2 2020
Melanoma - Pipeline by Constellation Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Convalife, H2 2020
Melanoma - Pipeline by Corvus Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by CStone Pharmaceuticals Co Ltd, H2 2020
Melanoma - Pipeline by Cue Biopharma Inc, H2 2020
Melanoma - Pipeline by Cura Therapeutics LLC, H2 2020
Melanoma - Pipeline by Curebiotech Inc, H2 2020
Melanoma - Pipeline by CureLab Oncology Inc, H2 2020
Melanoma - Pipeline by Curevac AG, H2 2020
Melanoma - Pipeline by Cynata Therapeutics Ltd, H2 2020
Melanoma - Pipeline by Cytocom Inc, H2 2020
Melanoma - Pipeline by Cytodyn Inc, H2 2020
Melanoma - Pipeline by CytoTools AG, H2 2020
Melanoma - Pipeline by CytoVac AS, H2 2020
Melanoma - Pipeline by CyTuVax BV, H2 2020
Melanoma - Pipeline by CZ BioMed Corp, H2 2020
Melanoma - Pipeline by Daiichi Sankyo Co Ltd, H2 2020
Melanoma - Pipeline by DC4U BV, H2 2020
Melanoma - Pipeline by Debiopharm International SA, H2 2020
Melanoma - Pipeline by Deciphera Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by DEKK-TEC Inc, H2 2020
Melanoma - Pipeline by Dicerna Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by DNAtrix Inc, H2 2020
Melanoma - Pipeline by Domain Therapeutics SA, H2 2020
Melanoma - Pipeline by Dracen Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Dragonfly Therapeutics Inc, H2 2020
Melanoma - Pipeline by Eisai Co Ltd, H2 2020
Melanoma - Pipeline by Eli Lilly and Co, H2 2020
Melanoma - Pipeline by Ella Therapeutics Ltd, H2 2020
Melanoma - Pipeline by Emcure Pharmaceuticals Ltd, H2 2020
Melanoma - Pipeline by ENB Therapeutics LLC, H2 2020
Melanoma - Pipeline by EnGeneIC Ltd, H2 2020
Melanoma - Pipeline by EntreChem SL, H2 2020
Melanoma - Pipeline by Epigene Therapeutics Inc, H2 2020
Melanoma - Pipeline by EpimAb Biotherapeutics Inc, H2 2020
Melanoma - Pipeline by Epizyme Inc, H2 2020
Melanoma - Pipeline by Epsilogen Ltd, H2 2020
Melanoma - Pipeline by Ervaxx Ltd, H2 2020
Melanoma - Pipeline by Eternity Bioscience Inc, H2 2020
Melanoma - Pipeline by eTheRNA Immunotherapies NV, H2 2020
Melanoma - Pipeline by Eucure (Beijing) Biopharma Co Ltd, H2 2020
Melanoma - Pipeline by Eutilex Co Ltd, H2 2020
Melanoma - Pipeline by Evaxion Biotech ApS, H2 2020
Melanoma - Pipeline by Evelo Biosciences Inc, H2 2020
Melanoma - Pipeline by EVOQ Therapeutics LLC, H2 2020
Melanoma - Pipeline by Evotec SE, H2 2020
Melanoma - Pipeline by Exelixis Inc, H2 2020
Melanoma - Pipeline by Exicure Inc, H2 2020
Melanoma - Pipeline by F. Hoffmann-La Roche Ltd, H2 2020
Melanoma - Pipeline by Faron Pharmaceuticals Oy, H2 2020
Melanoma - Pipeline by Fate Therapeutics Inc, H2 2020
Melanoma - Pipeline by Five Prime Therapeutics Inc, H2 2020
Melanoma - Pipeline by Flow Pharma Inc, H2 2020
Melanoma - Pipeline by Fochon Pharmaceutical Ltd, H2 2020
Melanoma - Pipeline by Galderma SA, H2 2020
Melanoma - Pipeline by Galectin Therapeutics Inc, H2 2020
Melanoma - Pipeline by GEEN Biotechnology Inc, H2 2020
Melanoma - Pipeline by Genelux Corp, H2 2020
Melanoma - Pipeline by Genemedicine Ltd, H2 2020
Melanoma - Pipeline by Genentech USA Inc, H2 2020
Melanoma - Pipeline by Generium, H2 2020
Melanoma - Pipeline by Genexine Inc, H2 2020
Melanoma - Pipeline by Genmab AS, H2 2020
Melanoma - Pipeline by Genocea Biosciences Inc, H2 2020
Melanoma - Pipeline by GigaGen Inc, H2 2020
Melanoma - Pipeline by Gilead Sciences Inc, H2 2020
Melanoma - Pipeline by GlaxoSmithKline Plc, H2 2020
Melanoma - Pipeline by GLG Pharma SA, H2 2020
Melanoma - Pipeline by GlycoNex Inc, H2 2020
Melanoma - Pipeline by Gmax Biopharm Ltd, H2 2020
Melanoma - Pipeline by GNT Biotech and Medicals Corp, H2 2020
Melanoma - Pipeline by Gradalis Inc, H2 2020
Melanoma - Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, H2 2020
Melanoma - Pipeline by Guangzhou FineImmune Biotechnology Co Ltd, H2 2020
Melanoma - Pipeline by Guangzhou Hanghua Bio Pharmaceutical Technology Co, H2 2020
Melanoma - Pipeline by HaimBio Ltd, H2 2020
Melanoma - Pipeline by Hangzhou Neoantigen Therapeutics Co Ltd, H2 2020
Melanoma - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2020
Melanoma - Pipeline by Harbin Gloria Pharmaceuticals Co Ltd, H2 2020
Melanoma - Pipeline by Harbour BioMed, H2 2020
Melanoma - Pipeline by Heat Biologics Inc, H2 2020
Melanoma - Pipeline by Hengenix Biotech Inc, H2 2020
Melanoma - Pipeline by Hercules Pharmaceuticals BV, H2 2020
Melanoma - Pipeline by Hibercell Inc, H2 2020
Melanoma - Pipeline by Highlight Therapeutics SL, H2 2020
Melanoma - Pipeline by HitGen Inc, H2 2020
Melanoma - Pipeline by Hookipa Pharma Inc, H2 2020
Melanoma - Pipeline by Horizon Therapeutics Plc, H2 2020
Melanoma - Pipeline by Hualan Biological Engineering Inc, H2 2020
Melanoma - Pipeline by HylaPharm, H2 2020
Melanoma - Pipeline by Ideaya Biosciences Inc, H2 2020
Melanoma - Pipeline by Idera Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Ikena Oncology Inc, H2 2020
Melanoma - Pipeline by ImCheck Therapeutics SAS, H2 2020
Melanoma - Pipeline by Immatics NV, H2 2020
Melanoma - Pipeline by Immodulon Therapeutics Ltd, H2 2020
Melanoma - Pipeline by ImmuneSensor Therapeutics Inc, H2 2020
Melanoma - Pipeline by Immunetune BV, H2 2020
Melanoma - Pipeline by ImmunityBio Inc, H2 2020
Melanoma - Pipeline by Immunocore Ltd, H2 2020
Melanoma - Pipeline by Immunophotonics Inc, H2 2020
Melanoma - Pipeline by ImmunoRestoration Inc, H2 2020
Melanoma - Pipeline by Immunos Therapeutics AG, H2 2020
Melanoma - Pipeline by ImmunSYS Inc, H2 2020
Melanoma - Pipeline by Immutep Ltd, H2 2020
Melanoma - Pipeline by Immvira Co Ltd, H2 2020
Melanoma - Pipeline by Imugene Ltd, H2 2020
Melanoma - Pipeline by Incuron LLC, H2 2020
Melanoma - Pipeline by Incyte Corp, H2 2020
Melanoma - Pipeline by Infinity Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by IngenoVax LLC, H2 2020
Melanoma - Pipeline by Inhibrx Inc, H2 2020
Melanoma - Pipeline by Inmune Bio Inc, H2 2020
Melanoma - Pipeline by Innate Pharma SA, H2 2020
Melanoma - Pipeline by Inner Mongolia Qite Biotechnology (Group) Co Ltd, H2 2020
Melanoma - Pipeline by InnoBioPharma LLC, H2 2020
Melanoma - Pipeline by Innovent Biologics Inc, H2 2020
Melanoma - Pipeline by Innovimmune Biotherapeutics Inc, H2 2020
Melanoma - Pipeline by Inovactis SAS, H2 2020
Melanoma - Pipeline by Inovio Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Instil Bio UK Ltd, H2 2020
Melanoma - Pipeline by IntelliStem Technologies Inc, H2 2020
Melanoma - Pipeline by Intensity Therapeutics Inc, H2 2020
Melanoma - Pipeline by InterK Peptide Therapeutics Ltd, H2 2020
Melanoma - Pipeline by InteRNA Technologies BV, H2 2020
Melanoma - Pipeline by InxMed Shanghai Co Ltd, H2 2020
Melanoma - Pipeline by IO Biotech ApS, H2 2020
Melanoma - Pipeline by iOnctura SA, H2 2020
Melanoma - Pipeline by Iovance Biotherapeutics Inc, H2 2020
Melanoma - Pipeline by iOx Therapeutics Ltd, H2 2020
Melanoma - Pipeline by ISOThrive Inc, H2 2020
Melanoma - Pipeline by Istari Oncology Inc, H2 2020
Melanoma - Pipeline by ISU ABXIS Co Ltd, H2 2020
Melanoma - Pipeline by iTeos Therapeutics Inc, H2 2020
Melanoma - Pipeline by JHL Biotech Inc, H2 2020
Melanoma - Pipeline by Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd, H2 2020
Melanoma - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2020
Melanoma - Pipeline by Jiangsu Sinorda Biomedicine Co Ltd, H2 2020
Melanoma - Pipeline by Johnson & Johnson, H2 2020
Melanoma - Pipeline by Jounce Therapeutics Inc, H2 2020
Melanoma - Pipeline by JS InnoPharm (Shanghai) Ltd, H2 2020
Melanoma - Pipeline by Jubilant Therapeutics Inc, H2 2020
Melanoma - Pipeline by Karus Therapeutics Ltd, H2 2020
Melanoma - Pipeline by Karyopharm Therapeutics Inc, H2 2020
Melanoma - Pipeline by Kine Sciences, H2 2020
Melanoma - Pipeline by Kineta Inc, H2 2020
Melanoma - Pipeline by Kinnate Biopharma Inc, H2 2020
Melanoma - Pipeline by Kitov Pharma Ltd, H2 2020
Melanoma - Pipeline by Kolon Life Science Inc, H2 2020
Melanoma - Pipeline by Komipharm International Co Ltd, H2 2020
Melanoma - Pipeline by Kringle Pharma Inc, H2 2020
Melanoma - Pipeline by Kuur Therapeutics Ltd, H2 2020
Melanoma - Pipeline by Kymab Ltd, H2 2020
Melanoma - Pipeline by Laboratorio Pablo Cassara SRL, H2 2020
Melanoma - Pipeline by Latima SIA, H2 2020
Melanoma - Pipeline by Learmont Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Leidos Health, H2 2020
Melanoma - Pipeline by Lentigen Technology Inc, H2 2020
Melanoma - Pipeline by Lepu Medical Technology (Beijing) Co Ltd, H2 2020
Melanoma - Pipeline by Ligand Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Light Chain Bioscience, H2 2020
Melanoma - Pipeline by Linnaeus Therapeutics Inc, H2 2020
Melanoma - Pipeline by LintonPharm Co Ltd, H2 2020
Melanoma - Pipeline by Lipo-Immuno Tech LLC, H2 2020
Melanoma - Pipeline by Lixte Biotechnology Holdings Inc, H2 2020
Melanoma - Pipeline by Lokon Pharma AB, H2 2020
Melanoma - Pipeline by Luye Pharma Group Ltd, H2 2020
Melanoma - Pipeline by Lytix Biopharma AS, H2 2020
Melanoma - Pipeline by Lyvgen Biopharma Ltd, H2 2020
Melanoma - Pipeline by MacroGenics Inc, H2 2020
Melanoma - Pipeline by MAIA Biotechnology Inc, H2 2020
Melanoma - Pipeline by Mateon Therapeutics Inc, H2 2020
Melanoma - Pipeline by MaxiVAX SA, H2 2020
Melanoma - Pipeline by MediaPharma SRL, H2 2020
Melanoma - Pipeline by Medicenna Therapeutics Corp, H2 2020
Melanoma - Pipeline by MediciNova Inc, H2 2020
Melanoma - Pipeline by MediGene AG, H2 2020
Melanoma - Pipeline by Mediolanum farmaceutici SpA, H2 2020
Melanoma - Pipeline by MedPacto Inc, H2 2020
Melanoma - Pipeline by Mekanistic Therapeutics LLC, H2 2020
Melanoma - Pipeline by MELEMA Pharma GmbH, H2 2020
Melanoma - Pipeline by Merck & Co Inc, H2 2020
Melanoma - Pipeline by Merck KGaA, H2 2020
Melanoma - Pipeline by Meryx Inc, H2 2020
Melanoma - Pipeline by MetabloQ Pty Ltd, H2 2020
Melanoma - Pipeline by MGC Pharmaceuticals Ltd, H2 2020
Melanoma - Pipeline by Microbiotica Ltd, H2 2020
Melanoma - Pipeline by Millennium Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Miltenyi Biotec BV & Co KG, H2 2020
Melanoma - Pipeline by Mirata Biopharma LLC, H2 2020
Melanoma - Pipeline by Mirati Therapeutics Inc, H2 2020
Melanoma - Pipeline by MiReven Pty Ltd, H2 2020
Melanoma - Pipeline by Mirrx Therapeutics A/S, H2 2020
Melanoma - Pipeline by Moderna Inc, H2 2020
Melanoma - Pipeline by Molecular Partners AG, H2 2020
Melanoma - Pipeline by Molecular Templates Inc, H2 2020
Melanoma - Pipeline by Moleculin Biotech Inc, H2 2020
Melanoma - Pipeline by Morphogenesis Inc, H2 2020
Melanoma - Pipeline by Mosaic ImmunoEngineering Inc, H2 2020
Melanoma - Pipeline by Multitude therapeutics Inc, H2 2020
Melanoma - Pipeline by MultiVir Inc, H2 2020
Melanoma - Pipeline by MyeloRx LLC, H2 2020
Melanoma - Pipeline by Nanjing Jinsirui Biotechnology Co Ltd, H2 2020
Melanoma - Pipeline by NantBioScience Inc, H2 2020
Melanoma - Pipeline by Nektar Therapeutics, H2 2020
Melanoma - Pipeline by Neoleukin Therapeutics Inc, H2 2020
Melanoma - Pipeline by Neonc Technologies Inc, H2 2020
Melanoma - Pipeline by NeoTX Therapeutics Ltd, H2 2020
Melanoma - Pipeline by Neumedicines Inc, H2 2020
Melanoma - Pipeline by New Amsterdam Sciences Inc, H2 2020
Melanoma - Pipeline by NewG Lab Pharma Inc, H2 2020
Melanoma - Pipeline by NexImmune Inc, H2 2020
Melanoma - Pipeline by NextCure Inc, H2 2020
Melanoma - Pipeline by NGM Biopharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Ningbo Wenda Pharma, H2 2020
Melanoma - Pipeline by Nirogyone Therapeutics LLC, H2 2020
Melanoma - Pipeline by Northwest Biotherapeutics Inc, H2 2020
Melanoma - Pipeline by Novartis AG, H2 2020
Melanoma - Pipeline by Noxopharm Ltd, H2 2020
Melanoma - Pipeline by Nubiyota LLC, H2 2020
Melanoma - Pipeline by Numab Therapeutics AG, H2 2020
Melanoma - Pipeline by Nynex Therapeutics LLC, H2 2020
Melanoma - Pipeline by Ocuphire Pharma Inc, H2 2020
Melanoma - Pipeline by OliPass Corporation, H2 2020
Melanoma - Pipeline by Omeros Corp, H2 2020
Melanoma - Pipeline by Ona Therapeutics SL, H2 2020
Melanoma - Pipeline by OncoArendi Therapeutics SA, H2 2020
Melanoma - Pipeline by OncoImmune Inc, H2 2020
Melanoma - Pipeline by Oncology Research International Ltd, H2 2020
Melanoma - Pipeline by Oncolys BioPharma Inc, H2 2020
Melanoma - Pipeline by Onconova Therapeutics Inc, H2 2020
Melanoma - Pipeline by Oncorus Inc, H2 2020
Melanoma - Pipeline by OncoSec Medical Inc, H2 2020
Melanoma - Pipeline by OncoTartis Inc, H2 2020
Melanoma - Pipeline by Oncotelic Inc, H2 2020
Melanoma - Pipeline by Oncovir Inc, H2 2020
Melanoma - Pipeline by Oneness Biotech Co Ltd, H2 2020
Melanoma - Pipeline by OnKure Inc, H2 2020
Melanoma - Pipeline by Ono Pharmaceutical Co Ltd, H2 2020
Melanoma - Pipeline by Orbis Health Solutions LLC, H2 2020
Melanoma - Pipeline by OrienGene Biotechnology Ltd, H2 2020
Melanoma - Pipeline by Orpheus Therapeutics Inc, H2 2020
Melanoma - Pipeline by Oxford BioTherapeutics Ltd, H2 2020
Melanoma - Pipeline by Pacific Northwest Biotechnology LLC, H2 2020
Melanoma - Pipeline by Pact Pharma Inc, H2 2020
Melanoma - Pipeline by Paranta Biosciences Ltd, H2 2020
Melanoma - Pipeline by Partner Therapeutics Inc, H2 2020
Melanoma - Pipeline by PCI Biotech Holding ASA, H2 2020
Melanoma - Pipeline by PDC Line Pharma SAS, H2 2020
Melanoma - Pipeline by PDS Biotechnology Corp, H2 2020
Melanoma - Pipeline by PDX Pharmaceuticals LLC, H2 2020
Melanoma - Pipeline by PepVax Inc, H2 2020
Melanoma - Pipeline by Pfizer Inc, H2 2020
Melanoma - Pipeline by Pharmaxis Ltd, H2 2020
Melanoma - Pipeline by Philogen SpA, H2 2020
Melanoma - Pipeline by Phio Pharmaceuticals Corp, H2 2020
Melanoma - Pipeline by Phoenix Life Sciences International Ltd, H2 2020
Melanoma - Pipeline by PHusis Therapeutics Inc, H2 2020
Melanoma - Pipeline by Pieris Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Pionyr Immunotherapeutics Inc, H2 2020
Melanoma - Pipeline by Plexxikon Inc, H2 2020
Melanoma - Pipeline by Plus Therapeutics Inc, H2 2020
Melanoma - Pipeline by PokeAcell, H2 2020
Melanoma - Pipeline by Polaris Pharmaceuticals Inc, H2 2020
Melanoma - Pipeline by Polynoma LLC, H2 2020
Melanoma - Pipeline by Polyplus-Transfection SA, H2 2020
Melanoma - Pipeline by Prestige BioPharma Pte Ltd, H2 2020
Melanoma - Pipeline by Primevax Immuno Oncology Inc, H2 2020
Melanoma - Pipeline by PRISM Pharma Co Ltd, H2 2020
Melanoma - Pipeline by Processa Pharmaceuticals Inc, H2 2020

List of Figures
List of Figures
Number of Products under Development for Melanoma, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020

Companies Mentioned: 

4D Pharma Plc
4SC AG
7 Hills Pharma LLC
AbbVie Inc
Abcuro Inc
Abion Inc
Abivax SA
ABM Therapeutics Inc
AC Bioscience SA
Accendatech Co Ltd
Accuitis Pharmaceuticals Inc
Acepodia Biotech Inc
ACF Pharmaceuticals LLC
Achilles Therapeutics Ltd
Actym Therapeutics Inc
Adaptimmune Therapeutics Plc
Adare Pharma Solutions
ADC Therapeutics SA
Adicet Bio Inc
Adjuvance Technologies Inc
Adlai Nortye Biopharma Co Ltd
Advanced BioDesign
Advantageous Systems LLC
Advenchen Laboratories LLC
Aeglea BioTherapeutics Inc
Afecta Pharmaceuticals Inc
Affichem SA
AgenTus Therapeutics Inc
Agenus Inc
AGV Discovery SAS
AIM ImmunoTech Inc
AIMM Therapeutics BV
AiVita Biomedical Inc
Akeso Inc
Alkermes Plc
Allarity Therapeutics A/S
Allergy Therapeutics Plc
Alligator Bioscience AB
AlphaMab Co Ltd
Alphamab Oncology
ALS Biopharma LLC
Altor Bioscience LLC
Amgen Inc
Anaveon AG
Andes Biotechnologies
AnGes Inc
Antengene Corp
AntiCancer Inc
APEIRON Biologics AG
Apexian Pharmaceuticals Inc
Apexigen Inc
Aphios Corp
APO-T BV
Apogenix AG
Apollomics Inc
Arcus Biosciences Inc
Ardan Pharma
Arisaph Pharmaceuticals Inc
Asana BioSciences LLC
Ascentage Pharma Group International
Astex Pharmaceuticals Inc
AstraZeneca Plc
Athenex Inc
Atreca Inc
aTyr Pharma Inc
Aurigene Discovery Technologies Ltd
Autolus Therapeutics Plc
Avalia Immunotherapies Ltd
AVAX Technologies Inc
Avidin Biotechnology Ltd
Avotres Inc
Bantam Pharmaceutical LLC
Barricade Therapeutics Corp
Batu Biologics Inc
Bayer AG
BeiGene Ltd
Beijing Kawin Technology Share-Holding Co Ltd
Beijing Neoantigen Biotechnology Co Ltd
BerGenBio ASA
Bessor Pharma LLC
Betta Pharmaceuticals Co Ltd
Binjiang Pharma, Inc.
Bio-Cancer Treatment International Ltd
Bio-Thera Solutions Ltd
BioAtla LLC
Biocad
Biogazelle NV
Biogen Inc
Biohaven Pharmaceutical Holding Company Ltd
BioInvent International AB
BioLineRx Ltd
BioMed Valley Discoveries Inc
Bionomics Ltd
BioNTech SE
Bioquark Inc
Biosion Inc
BioVaxys Technology Corp
Biovista Inc
BioXcel Therapeutics Inc
BJ Bioscience Inc
Boehringer Ingelheim International GmbH
BriaCell Therapeutics Corp
BridgeBio Pharma Inc
BrightPath Biotherapeutics Co Ltd
Bristol-Myers Squibb Co
Bromodomain Pharmaceuticals Inc
Byondis BV
Calidi Biotherapeutics Inc
Calithera Biosciences Inc
Can-Fite BioPharma Ltd
Cancure Ltd
Cantargia AB
CDR-Life Inc
Celdara Medical LLC
Celldex Therapeutics Inc
Cellestia Biotech AG
Cellid Co Ltd
Celprogen Inc
Centurion BioPharma Corp
Checkmate Pharmaceuticals Inc
Checkpoint Therapeutics Inc
Chineo Med Beijing Co Ltd
Chinook Therapeutics Inc
Chugai Pharmaceutical Co Ltd
Cloaked Therapeutics LLC
Codagenix Inc
Codiak BioSciences Inc
CohBar Inc
Constellation Pharmaceuticals Inc
Convalife
Corvus Pharmaceuticals Inc
CStone Pharmaceuticals Co Ltd
Cue Biopharma Inc
Cura Therapeutics LLC
Curebiotech Inc
CureLab Oncology Inc
Curevac AG
Cynata Therapeutics Ltd
Cytocom Inc
Cytodyn Inc
CytoTools AG
CytoVac AS
CyTuVax BV
CZ BioMed Corp
Daiichi Sankyo Co Ltd
DC4U BV
Debiopharm International SA
Deciphera Pharmaceuticals Inc
DEKK-TEC Inc
Dicerna Pharmaceuticals Inc
DNAtrix Inc
Domain Therapeutics SA
Dracen Pharmaceuticals Inc
Dragonfly Therapeutics Inc
Eisai Co Ltd
Eli Lilly and Co
Ella Therapeutics Ltd
Emcure Pharmaceuticals Ltd
ENB Therapeutics LLC
EnGeneIC Ltd
EntreChem SL
Epigene Therapeutics Inc
EpimAb Biotherapeutics Inc
Epizyme Inc
Epsilogen Ltd
Ervaxx Ltd
Eternity Bioscience Inc
eTheRNA Immunotherapies NV
Eucure (Beijing) Biopharma Co Ltd
Eutilex Co Ltd
Evaxion Biotech ApS
Evelo Biosciences Inc
EVOQ Therapeutics LLC
Evotec SE
Exelixis Inc
Exicure Inc
F. Hoffmann-La Roche Ltd
Faron Pharmaceuticals Oy
Fate Therapeutics Inc
Five Prime Therapeutics Inc
Flow Pharma Inc
Fochon Pharmaceutical Ltd
Galderma SA
Galectin Therapeutics Inc
GEEN Biotechnology Inc
Genelux Corp
Genemedicine Ltd
Genentech USA Inc
Generium
Genexine Inc
Genmab AS
Genocea Biosciences Inc
GigaGen Inc
Gilead Sciences Inc
GlaxoSmithKline Plc
GLG Pharma SA
GlycoNex Inc
Gmax Biopharm Ltd
GNT Biotech and Medicals Corp
Gradalis Inc
Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangzhou FineImmune Biotechnology Co Ltd
Guangzhou Hanghua Bio Pharmaceutical Technology Co
HaimBio Ltd
Hangzhou Neoantigen Therapeutics Co Ltd
Hanmi Pharmaceuticals Co Ltd
Harbin Gloria Pharmaceuticals Co Ltd
Harbour BioMed
Heat Biologics Inc
Hengenix Biotech Inc
Hercules Pharmaceuticals BV
Hibercell Inc
Highlight Therapeutics SL
HitGen Inc
Hookipa Pharma Inc
Horizon Therapeutics Plc
Hualan Biological Engineering Inc
HylaPharm
Ideaya Biosciences Inc
Idera Pharmaceuticals Inc
Ikena Oncology Inc
ImCheck Therapeutics SAS
Immatics NV
Immodulon Therapeutics Ltd
ImmuneSensor Therapeutics Inc
Immunetune BV
ImmunityBio Inc
Immunocore Ltd
Immunophotonics Inc
ImmunoRestoration Inc
Immunos Therapeutics AG
ImmunSYS Inc
Immutep Ltd
Immvira Co Ltd
Imugene Ltd
Incuron LLC
Incyte Corp
Infinity Pharmaceuticals Inc
IngenoVax LLC
Inhibrx Inc
Inmune Bio Inc
Innate Pharma SA
Inner Mongolia Qite Biotechnology (Group) Co Ltd
InnoBioPharma LLC
Innovent Biologics Inc
Innovimmune Biotherapeutics Inc
Inovactis SAS
Inovio Pharmaceuticals Inc
Instil Bio UK Ltd
IntelliStem Technologies Inc
Intensity Therapeutics Inc
InterK Peptide Therapeutics Ltd
InteRNA Technologies BV
InxMed Shanghai Co Ltd
IO Biotech ApS
iOnctura SA
Iovance Biotherapeutics Inc
iOx Therapeutics Ltd
ISOThrive Inc
Istari Oncology Inc
ISU ABXIS Co Ltd
iTeos Therapeutics Inc
JHL Biotech Inc
Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Sinorda Biomedicine Co Ltd
Johnson & Johnson
Jounce Therapeutics Inc
JS InnoPharm (Shanghai) Ltd
Jubilant Therapeutics Inc
Karus Therapeutics Ltd
Karyopharm Therapeutics Inc
Kine Sciences
Kineta Inc
Kinnate Biopharma Inc
Kitov Pharma Ltd
Kolon Life Science Inc
Komipharm International Co Ltd
Kringle Pharma Inc
Kuur Therapeutics Ltd
Kymab Ltd
Laboratorio Pablo Cassara SRL
Latima SIA
Learmont Pharmaceuticals Inc
Leidos Health
Lentigen Technology Inc
Lepu Medical Technology (Beijing) Co Ltd
Ligand Pharmaceuticals Inc
Light Chain Bioscience
Linnaeus Therapeutics Inc
LintonPharm Co Ltd
Lipo-Immuno Tech LLC
Lixte Biotechnology Holdings Inc
Lokon Pharma AB
Luye Pharma Group Ltd
Lytix Biopharma AS
Lyvgen Biopharma Ltd
MacroGenics Inc
MAIA Biotechnology Inc
Mateon Therapeutics Inc
MaxiVAX SA
MediaPharma SRL
Medicenna Therapeutics Corp
MediciNova Inc
MediGene AG
Mediolanum farmaceutici SpA
MedPacto Inc
Mekanistic Therapeutics LLC
MELEMA Pharma GmbH
Merck & Co Inc
Merck KGaA
Meryx Inc
MetabloQ Pty Ltd
MGC Pharmaceuticals Ltd
Microbiotica Ltd
Millennium Pharmaceuticals Inc
Miltenyi Biotec BV & Co KG
Mirata Biopharma LLC
Mirati Therapeutics Inc
MiReven Pty Ltd
Mirrx Therapeutics A/S
Moderna Inc
Molecular Partners AG
Molecular Templates Inc
Moleculin Biotech Inc
Morphogenesis Inc
Mosaic ImmunoEngineering Inc
Multitude therapeutics Inc
MultiVir Inc
MyeloRx LLC
Nanjing Jinsirui Biotechnology Co Ltd
NantBioScience Inc
Nektar Therapeutics
Neoleukin Therapeutics Inc
Neonc Technologies Inc
NeoTX Therapeutics Ltd
Neumedicines Inc
New Amsterdam Sciences Inc
NewG Lab Pharma Inc
NexImmune Inc
NextCure Inc
NGM Biopharmaceuticals Inc
Ningbo Wenda Pharma
Nirogyone Therapeutics LLC
Northwest Biotherapeutics Inc
Novartis AG
Noxopharm Ltd
Nubiyota LLC
Numab Therapeutics AG
Nynex Therapeutics LLC
Ocuphire Pharma Inc
OliPass Corporation
Omeros Corp
Ona Therapeutics SL
OncoArendi Therapeutics SA
OncoImmune Inc
Oncology Research International Ltd
Oncolys BioPharma Inc
Onconova Therapeutics Inc
Oncorus Inc
OncoSec Medical Inc
OncoTartis Inc
Oncotelic Inc
Oncovir Inc
Oneness Biotech Co Ltd
OnKure Inc
Ono Pharmaceutical Co Ltd
Opsona Therapeutics Ltd
Orbis Health Solutions LLC
OrienGene Biotechnology Ltd
Orpheus Therapeutics Inc
Oxford BioTherapeutics Ltd
Pacific Northwest Biotechnology LLC
Pact Pharma Inc
Paranta Biosciences Ltd
Partner Therapeutics Inc
PCI Biotech Holding ASA
PDC Line Pharma SAS
PDS Biotechnology Corp
PDX Pharmaceuticals LLC
PepVax Inc
Pfizer Inc
Pharmaxis Ltd
Philogen SpA
Phio Pharmaceuticals Corp
Phoenix Life Sciences International Ltd
PHusis Therapeutics Inc
Pieris Pharmaceuticals Inc
Pionyr Immunotherapeutics Inc
Plexxikon Inc
Plus Therapeutics Inc
PokeAcell
Polaris Pharmaceuticals Inc
Polynoma LLC
Polyplus-Transfection SA
Prestige BioPharma Pte Ltd
Primevax Immuno Oncology Inc
PRISM Pharma Co Ltd
Processa Pharmaceuticals Inc
Promore Pharma AB
Propanc Biopharma Inc
Protheragen Inc
Provectus Biopharmaceuticals Inc
Provenance Biopharmaceuticals Corp
Puma Biotechnology Inc
Puretech Health Plc
PYCTX Ltd
QBiotics Ltd
Qilu Puget Sound Biotherapeutics Corp
Qu Biologics Inc
Quadriga BioSciences Inc
RadImmune Therapeutics Inc
Reata Pharmaceuticals Inc
Recombio SL
Regeneron Pharmaceuticals Inc
Resonant Therapeutics Inc
RetroVirox Inc
Reven Pharmaceuticals Inc
RHEACELL GmbH & Co KG
Rubicon Biotechnology Inc
Rubius Therapeutics Inc
Salarius Pharmaceuticals Inc
SANOCHEMIA Pharmazeutika GmbH
Sanofi
Sapience Therapeutics Inc
SATT Nord
Scancell Holdings Plc
Scholar Rock Inc
Scopus BioPharma Inc
Seagen Inc
Seres Therapeutics Inc
Seven and Eight Biopharmaceuticals Corp
Shandong Taize Huikang Biomedical Co Ltd
Shanghai De Novo Pharmatech Co Ltd
Shanghai Haihe Biopharma Co Ltd
Shanghai Hycharm Inc
Shanghai Junshi Bioscience Co Ltd
Shattuck Labs Inc
Shenogen Pharma听Group Ltd
Shenzhen Chipscreen Biosciences Co Ltd
Shouyao Holding Co Ltd
Sichuan Haisco Pharmaceutical Co Ltd
Sichuan Huiyang Life Science and Technology Corp
SilaGene Inc
Sillajen Biotherapeutics
Sino Biopharmaceutical Ltd
Sirnaomics Inc
Sonnet BioTherapeutics Holdings Inc
Sonoval LLC
Sotio AS
Spring Bank Pharmaceuticals Inc
SpringWorks Therapeutics Inc
Sprint Bioscience AB
Starwise Therapeutics LLC
STAT3 Therapeutics Inc
Stcube Inc
Stella Pharmaceuticals Pvt Ltd
Sumitomo Dainippon Pharma Co Ltd
Sumitomo Dainippon Pharma Oncology, Inc
Suntec Medical (Taiwan) Inc
Susavion Biosciences Inc
SuviCa Inc
Suzhou Everhealth Biomedical Co Ltd
Suzhou Maximum Bio-tech Co Ltd
Syndivia SAS
Synthis LLC
Syntrix Biosystems Inc
Systimmune Inc
Tactical Therapeutics Inc
Tactiva Therapeutics LLC
TAE Life Sciences LLC
Taiga Biotechnologies Inc
TaiRx Inc
Takara Bio Inc
Takis Srl
Targovax ASA
TCR Cure Biopharma Technology Co Ltd
Telesis Therapeutics LLC
Tevogen Bio Inc
TheraPten Biosciences Inc
Theratechnologies Inc
Theravectys SA
Tidal Therapeutics Inc
Tikcro Technologies Ltd
TILT Biotherapeutics Ltd
Timmune Biotech Inc
Tmunity Therapeutics Inc
Tollbridge Therapeutics LLC
Torque Therapeutics Inc
Transcode听Therapeutics Inc
Treadwell Therapeutics Inc
TREAT U SA
Treos Bio Ltd
Turning Point Therapeutics Inc
Turnstone Biologics Inc
Tvardi Therapeutics Inc
TVAX Biomedical Inc
UBI Pharma Inc
UbiVac LLC
Ultimovacs AS
Vaccinex Inc
Vacthera BioTech GmbH
Valo Therapeutics Oy
Vascular Biogenics Ltd
Vault Pharma Inc
Vaxess Technologies Inc
Vaxil Bio Therapeutics Ltd
Veana Therapeutics LLC
Vedanta Biosciences Inc
Verastem Inc
VerImmune Inc
Veru Inc
Vichem Chemie Research Ltd
Viewpoint Molecular Targeting LLC
Viralytics Pty Ltd
Virocure Inc
ViruCure Therapeutics Ltd
VM Discovery Inc
VREX Therapeutics Inc
Vyriad Inc
WntResearch AB
Wuhan Binhui Biotechnology Co Ltd
Wuhan YZY Biopharma Co Ltd
X4 Pharmaceuticals Inc
Xbrane Biopharma AB
Xcovery Holding Co LLC
XEME BioPharma Inc
Xencor Inc
Xiangxue Life Sciences
Xynomic Pharmaceuticals Holdings Inc
Y-Biologics Inc
Y-mAbs Therapeutics Inc
Yooyoung Pharm Co Ltd
Yukin Therapeutics SAS
Zelluna Immunotherapy AS
Zhejiang Teruisi Pharmaceutical Co Ltd
Zhejiang Yangshengtang Biotech Co Ltd

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/global-markets-direct/melanoma-pipeline-review-h2-2020

Links
[1] /countries/global[2] /drug-pipeline[3] /pharma-healthcare